Including over 10,000 patients with high CRP levels who had had a previous myocardial infarction and were studied over 4 years, this trial showed a significantly lower rate of recurrent cardiovascular events as well as reduced CRP levels (Ridker et al.2017). The gene discussed is CRP; the disease is myocardial infarction.